Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Structure-Based Drug Discovery (eBook)

An Overview

Roderick E Hubbard (Herausgeber)

eBook Download: PDF
2007
278 Seiten
Royal Society of Chemistry (Verlag)
978-1-84755-254-9 (ISBN)

Lese- und Medienproben

Structure-Based Drug Discovery -
Systemvoraussetzungen
179,99 inkl. MwSt
(CHF 175,85)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
A collection of methods to determine and analyse the 3-D structure of biomolecules. These methods have been enhanced to improve the speed and quality of drug discovery.
Structure-based drug discovery is a collection of methods that exploits the ability to determine and analyse the three dimensional structure of biological molecules. These methods have been adopted and enhanced to improve the speed and quality of discovery of new drug candidates. After an introductory overview of the principles and application of structure-based methods in drug discovery, this book then describes the essential features of the various methods. Chapters on X-ray crystallography, NMR spectroscopy, and computational chemistry and molecular modelling describe how these particular techniques have been enhanced to support rational drug discovery, with discussions on developments such as high throughput structure determination, probing protein-ligand interactions by NMR spectroscopy, virtual screening and fragment-based drug discovery. The concluding chapters complement the overview of methods by presenting case histories to demonstrate the major impact that structure-based methods have had on discovering drug molecules. Written by international experts from industry and academia, this comprehensive introduction to the methods and practice of structure-based drug discovery not only illustrates leading-edge science but also provides the scientific background for the non-expert reader. The book provides a balanced appraisal of what structure-based methods can and cannot contribute to drug discovery. It will appeal to industrial and academic researchers in pharmaceutical sciences, medicinal chemistry and chemical biology, as well as providing an insight into the field for recent graduates in the biomolecular sciences.

Chapter 1: 3D Structure and the Drug Discovery Process; 1: Introduction; 2: The Drug Discovery Process; 3: What is Structure-based Drug Discovery?; 4: The Evolution of the Ideas of Structure-based Drug Discovery; 5: What isn't in this Book; 6: Concluding Remarks; References; Chapter 2: Structure Detemination - Crystallography for Structure-based Drug Design; 1: What is X-ray Crystallography?; 2: What is required to Produce a Crystal Structure?; 3: Crystallisability of Proteins; 4: How Does the X-ray Data Relate to the Electron Density? The Phase Problem; 5: Electron Density Map Interpretation and Atomic Model of the Protein; 6: Useful Crystallographic Therminology when Utilising Crystal Structures; 7: The Structure Determination Process; 8: Recent technological Advances; 9: The Role of Crystal Structures in the Discovery Process; 10: The Optimal SBDD System; 11: The Impact of Structural Genomics; 12: Producing a Biologically Relevant Structure; 13: Phosphorylation; 14: Balancing Solubility with Crystallisability; 15: Engineering Solubility; 16: Specific Crystal Packing Engineering; 17: Engineering Stability; 18: Use of Surrogate Proteins; References; Chapter 3: Molecular Modelling; 1: Introduction; 2: Methods; 3: Applications; 4: Conclusion; References; Chapter 4: Applications of NMR in Structure-based Drug Design; 1: Introduction; 2: Studying Ligand/Receptor Interactions by NMR; 3: NMR in Structure-based Lead Optimization; 4: Other Applications of NMR in SBDD; 5: Conclusion and Outlook; References; Chapter 5:Fragment Screening - An Introduction; 1: Introduction; 2: The Concept of Drug Likeness; 3: The Evolution of Lead-likeness and Fragment Screening; 4: Finding Fragments by Screening; 5: The Design of Fragment Screening Sets; 6: Turning Fragment Hits into Leads; 7:Summary; References; Chapter 6: Iterative Structure-based Screening of Virtual Chemical Libraries and Factor Xa: Finding the Orally Available Antithrombotic Candadate LY517717; 1: Introduction; 2: Morphology of the Factor Xa Active Site; 3: Structure-based Library Design; 4: Design Strategy for Factor Xa; 5: Introducing Oral Availability; 6: Non-basic S1 Series; 7: Oral Antithrombotic Activity; 8: Conclusion; References; Chapter 7: Anti-influenza Drugs from Sialidase Inhibitors; 1: Introduction; 2: Influenza Viruses; 3: Early Attempts to Discover Neuraminidase Inhibitors; 4: Neuraminidase Structure; 5: Structure-based Discovery of Inhibitors; 6: Retrospective Analyses of Inhibitor-binding; 7: Laboratory Studies of Inhibitor Resistant Variants; 8: Clinical Studies of Drug Resistance; 9: Drug Profiles; Conclusions; References; Chapter 8: Isoform Specificity: The Design of Estrogen Receptor- Selective Compounds; 1: Introduction; 2: Structure-based Design Methodology; 3: The Design of Aryl Diphenolic Azoles as ER? Selective Agonists; 4: Learning From and Moving Beyond the Genistein Scaffold; 5: Evaluation of ER? Selective Compounds in Biological Assays; Conclusions; Acknowledgements; References

Erscheint lt. Verlag 31.10.2007
Reihe/Serie ISSN
ISSN
Co-Autor David Brown, Maria M Flocco, Xavier Barril, Robert Soliva, Ben Davis, Julia Hubbard, Andrew Leach, Michael Hann, Jeremy N Burrows, Ed Griffen, John Liebschutz, Stuart D Jones, Michael R Wiley, Steven C Young, Peter Colman, Eric S Manas, Richard E Mewshaw, Heather A Harris, Michael S Malamas
Verlagsort Cambridge
Sprache englisch
Themenwelt Sachbuch/Ratgeber Freizeit / Hobby Sammeln / Sammlerkataloge
Medizin / Pharmazie Gesundheitsfachberufe
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Chemie
Technik
Schlagworte Discovery • Drug • Overview • Structure
ISBN-10 1-84755-254-4 / 1847552544
ISBN-13 978-1-84755-254-9 / 9781847552549
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
The Process of Leading Organizational Change

von Donald L. Anderson

eBook Download (2023)
Sage Publications (Verlag)
CHF 102,55
Interpreter of Constitutionalism in Japan

von Frank O. Miller

eBook Download (2023)
University of California Press (Verlag)
CHF 47,85